Skip to main content

Advertisement

SpringerLink
Log in

Flattening of retinal pigment epithelial detachments after pneumatic displacement of submacular hemorrhages secondary to age-related macular degeneration

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

Pneumatic displacement of submacular hemorrhages (SMHs) with intravitreal injection of sulfur hexafluoride (SF6) gas with or without tissue plasminogen activator (tPA) and prone posturing is an effective minimally invasive treatment. We observed some cases in which simultaneous flattening of hemorrhagic pigment epithelial detachments (PEDs) occurred after prone posturing. This study evaluated the impact of pneumatic displacement using tPA to treat PEDs and visual outcomes in eyes with SMHs secondary to neovascular age-related macular degeneration (AMD).

Methods

This retrospective analysis reviewed the medical records of 32 patients (33 eyes) who underwent pneumatic displacement for AMD-associated SMHs. The SMHs were related to polypoidal choroidal vasculopathy (PCV) in 24 eyes and typical AMD in nine eyes and treated with intravitreal injection of SF6 gas with tPA. We assessed the postoperative best-corrected visual acuities (BCVAs), prevalence and flattening rates of the PEDs, and the number of additional treatments.

Results

The mean follow-up period was 35.4 ± 19.8 months. The BCVAs improved significantly in eyes with PCV compared with eyes with typical AMD. Thirty-one (93.9%) of 33 eyes had an accompanying PED. The PEDs flattened in 14 (58.3%) of 24 eyes with PCV but in only one (14.3%) of seven eyes with typical AMD (p = 0.04). A mean of one additional treatment was administered during the first year in 15 eyes with flattened PEDs, which was significantly (p < 0.05) fewer than the 3.6 additional treatments in 16 eyes with persistent PEDs.

Conclusions

PEDs often accompany SMHs secondary to neovascular AMD. Pneumatic displacement of the SMHs using tPA unexpectedly flattened the PEDs, especially in eyes with PCV, and was associated with fewer additional treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Benner JD, Hay A, Landers MB III, Hjelmeland LM, Morse LS (1994) Fibrinolytic-assisted removal of experimental subretinal hemorrhage within seven days reduces outer retinal degeneration. Ophthalmology 101:672–681

    Article  PubMed  CAS  Google Scholar 

  2. Toth CA, Morse LS, Hjelmeland LM, Landers MB III (1991) Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol 109:723–729

    Article  PubMed  CAS  Google Scholar 

  3. Ohji M, Saito Y, Hayashi A, Lewis JM, Tano Y (1998) Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 116:1326–1332

    Article  PubMed  CAS  Google Scholar 

  4. Mizutani T, Yasukawa T, Ito Y, Takase A, Hirano Y, Yoshida M, Ogura Y (2011) Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol 249:1153–1157

    Article  PubMed  CAS  Google Scholar 

  5. Schulze SD, Hesse L (2002) Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome. Graefes Arch Clin Exp Ophthalmol 240:717–720

    Article  PubMed  CAS  Google Scholar 

  6. Chen CY, Hooper C, Chiu D, Chamberlain M, Karia N, Heriot WJ (2007) Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas. Retina 27:321–328

    Article  PubMed  Google Scholar 

  7. Tsymanava A, Uhlig CE (2012) Intravitreal recombinant tissue plasminogen activator without and with additional gas injection in patients with submacular haemorrhage associated with age-related macular degeneration. Acta Ophthalmol 90:633–638

    Article  PubMed  Google Scholar 

  8. Kitahashi M, Baba T, Sakurai M, Yokouchi H, Kubota-Taniai M, Mitamura Y, Yamamoto S (2014) Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy. Clin Ophthalmol 8:485–492

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Meyer CH, Scholl HP, Eter N, Helb HM, Holz FG (2008) Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study. Acta Ophthalmol 86:490–494

    Article  PubMed  CAS  Google Scholar 

  10. Matt G, Sacu S, Stifter E, Prunte C, Schmidt-Erfurth U (2010) Combination of intravitreal rTPA, gas and ranibizumab for extensive subfoveal haemorrhages secondary to neovascular age-related macular degeneration. Klin Monatsbl Augenheilkd 227:221–225

    Article  PubMed  CAS  Google Scholar 

  11. Guthoff R, Guthoff T, Meigen T, Goebel W (2011) Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration. Retina 31:36–40

    Article  PubMed  CAS  Google Scholar 

  12. Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC (2014) Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration. Am J Ophthalmol 157:1250–1257

    Article  PubMed  CAS  Google Scholar 

  13. Arias L, Mones J (2010) Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration. Clin Ophthalmol 4:67–72

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kamei M, Tano Y, Maeno T, Ikuno Y, Mitsuda H, Yuasa T (1996) Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol 121:267–275

    Article  PubMed  CAS  Google Scholar 

  15. Moisseiev E, Ben Ami T, Barak A (2014) Vitrectomy and subretinal injection of tissue plasminogen activator for large submacular hemorrhage secondary to AMD. Eur J Ophthalmol 24:925–931

    Article  PubMed  Google Scholar 

  16. Kimura S, Morizane Y, Hosokawa M, Shiode Y, Kawata T, Doi S, Matoba R, Hosogi M, Fujiwara A, Inoue Y, Shiraga F (2015) Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator. Am J Ophthalmol 159:683–689

    Article  PubMed  CAS  Google Scholar 

  17. Kadonosono K, Arakawa A, Yamane S, Inoue M, Yamakawa T, Uchio E, Yanagi Y (2015) Displacement of submacular hemorrhages in age-related macular degeneration with subretinal tissue plasminogen activator and air. Ophthalmology 122:123–128

    Article  PubMed  Google Scholar 

  18. Heriot WJ (1996) Intravitreal gas and TPA: an outpatient procedure for submacular hemorrhage. American Academy of Ophthalmology Annual Vitreoretinal Update, Chicago, IL

    Google Scholar 

  19. Heriot WJ (1997) Further experience in management of submacular hemorrhage with intravitreal tPA. In: Proceedings of the 1997 update on macular surgery. American Academy of Ophthalmology, San Francisco, CA, pp 82–84

    Google Scholar 

  20. Treumer F, Roider J, Hillenkamp J (2012) Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage. Br J Ophthalmol 96:708–713

    Article  PubMed  Google Scholar 

  21. Kunavisarut P, Thithuan T, Patikulsila D, Choovuthayakorn J, Watanachai N, Chaikitmongkol V, Pathanapitoon K, Rothova A (2017) Submacular hemorrhage: visual outcomes and prognostic factors. Asia Pac J Ophthalmol https://doi.org/10.22608/APO.2017389

  22. Yanyali A, Aytug B, Horozoglu F, Nohutcu AF (2007) Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes. Am J Ophthalmol 144:124–126

    Article  PubMed  CAS  Google Scholar 

  23. Treumer F, Wienand S, Purtskhvanidze K, Roider J, Hillenkamp J (2017) The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF. Graefes Arch Clin Exp Ophthalmol 255:1115–1123

    Article  PubMed  CAS  Google Scholar 

  24. Hrach CJ, Johnson MW, Hassan AS, Lei B, Sieving PA, Elner VM (2000) Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes. Arch Ophthalmol 118:659–663

    Article  PubMed  CAS  Google Scholar 

  25. Johnson MW, Olsen KR, Hernandez E, Irvine WD, Johnson RN (1990) Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol 108:259–263

    Article  PubMed  CAS  Google Scholar 

  26. Irvine WD, Johnson MW, Hernandez E, Olsen KR (1991) Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes. Arch Ophthalmol 109:718–722

    Article  PubMed  CAS  Google Scholar 

  27. Hesse L, Schmidt J, Kroll P (1999) Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol 237:273–277

    Article  PubMed  CAS  Google Scholar 

  28. Chen SN, Yang TC, Ho CL, Kuo YH, Yip Y, Chao AN (2003) Retinal toxicity of intravitreal tissue plasminogen activator: case report and literature review. Ophthalmology 110:704–708

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Kawasumi 1, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan

    Masayo Kimura, Tsutomu Yasukawa, Yu Shibata, Aki Kato, Yoshio Hirano, Akiyoshi Uemura, Munenori Yoshida & Yuichiro Ogura

Authors
  1. Masayo Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tsutomu Yasukawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu Shibata
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Aki Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yoshio Hirano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Akiyoshi Uemura
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Munenori Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yuichiro Ogura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tsutomu Yasukawa.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

For this type of study, formal consent is not required.

Informed consent

Opt-out consent method was chosen, approved by the institutional review board of Nagoya City University Graduate School of Medical Sciences because no information identifying individual participants was involved in this article.

Additional information

The authors have no proprietary interest in any aspect of this report.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kimura, M., Yasukawa, T., Shibata, Y. et al. Flattening of retinal pigment epithelial detachments after pneumatic displacement of submacular hemorrhages secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 256, 1823–1829 (2018). https://doi.org/10.1007/s00417-018-4059-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-018-4059-9

Keywords

Search

Navigation